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Introduction 
 
The chronic phantom perception of sound, or 
tinnitus, places a significant burden on 
emotional well-being and disrupts daily living in 
a large proportion of the general population. 
Depending on the level of diagnostic stringency, 
in the U.S.A. between 8% and 25% of adults 
fulfill lifetime criteria for the disorder [1]. 
Tinnitus may be conceptualized as a state of 
central nervous hyperexcitability that is 
frequently precipitated and maintained by 
stressful environments, but can also induce 
adaptation processes and resolve under 
favourable circumstances [2]. The precise 
biological underpinnings of chronic tinnitus are 
unknown and current data suggest that only 3% 
of European cases are exclusively attributable 
to environmental noise exposure [3]. There is 
however, an increasing interest in genetic traits 
that may be associated with the phenotype [4]. 
Preliminary estimates of heritability range from 
0.11 to 0.39 [5, 6] and are best compatible with 
many causative genes exerting minor effects. 
 
Evidence is accumulating that adaptation to 
tinnitus is highly dependent on neural plasticity 
and on the restoration of dysfunctional auditory 
circuits for tuning out the phantom noise signal 
[7-11]. In animal models, tinnitus is 
accompanied by peripheral signs of ongoing 
regeneration [12] and by the remodeling of 
entire neural circuits [13, 14]. These responses 
to tinnitus correlate with the expression of 
neurotrophic factors [15], fuelling interests in 
the curative use of such factors [16]. An 
emerging role for glial cells in the restoration of 
auditory function [17] and the confirmed 
preventive effects of brain-derived neurotrophic 
factor (BDNF) on damage to the auditory 
pathway by tinnitus-inducing agents [18], or by 
acoustic trauma [19] further rationalize the 
search for related biomarkers. 
 
The present investigation addresses genetic 
variants in the genes encoding glial cell-derived 
neurotrophic factor (GDNF) and BDNF in 
tinnitus, of which one missense substitution, 
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BDNF Val66Met, has already been the object of 
extensive investigations in the sensitivity to 
stress [20]. Empirical data support additional 
roles in the adaptation to stress and noise [21, 
22], in the processing of auditory information, 
e.g., during acoustic startle [23], in auditory 
odball tasks [24], and in other auditory 
challenges [25]. It is noteworthy that positive 
associations have also been reported for 
auditory hallucinations in some settings [26]. 
Together, these findings argue in favor of a 
modulatory effect on sound perception, 
generation and processing beyond guiding early 
development of the auditory pathway. 
 
Materials and methods 
 
Subjects 
 
In 240 German outpatients (171 men and 69 
women, age 50.3 ±12.9 years, mean ± SD) 
consulting for chronic tinnitus, the diagnosis 
was confirmed by a detailed neurootological 
examination including otoscopy, stapedius 
reflexes, middle ear pressure measurements, 
and pure tone audiometry. The degree of 
hearing loss was calculated as the binaural 
pure tone average involving air conduction 
across seven test frequencies (0.125, 0.25, 
0.5, 1, 2, 4, and 8kHz). For the present study, 
only patients with subjective tinnitus were 
included. Tinnitus severity was assessed by the 
German version of the Tinnitus Questionnnaire 
(TQ) [27]. All participants were Cauacasians and 
a majority originated from the Upper Palatinate 
region of Bavaria. All provided informed consent 
and the study was approved by the local ethics 
committee at the University of Regensburg. 
 
Genotyping 
 
Genomic DNA was extracted from lymphocytes 
using standard procedures prior to generating 
GDNF and BDNF amplicons for PCR-based 
RFLPs. Variants were selected based on 
functionality (rs6265), linkage disequilibrium 
(LD) tagging properties (rs2049046, 
rs1110149), and high heterozygosity estimates 
(remaining variants). Briefly, the following 
primer pairs were designed: 5'-CAT TTA CTG AGC 
TCT TAC TAC ATG TTC C-3' (rs3812047, 
forward), 5'-TCC TTG CAA GTC CCC AGT TC-
3' (rs3812047, reverse), 5'-GCC CTT TCT ACA 
CAT CTT TTA CCT C-3' (rs1110149, forward), 5'-
TGC TAA AGT GTG GAG AGT CTA AGT C-
3' (rs1110149 and rs884344, reverse), 5'-GGC 
TCT CCT GAT CCA TTT TG-3' (rs884344, 
forward), 5'-GAA AAA CGC ACA CAC ACA GAA-
3' (rs2049046, forward), and 5'-CCA AGA CCC 
TTG AAG AGA ACT TAT-3' (rs2049046, reverse). 
For rs6265, we used previously published 
primers [28]. Following incubation with 
restriction endonucleases (FokI for rs3812047, 
ApaI for rs1110149, NdeI for rs884344, Eco72I 
for rs6265, and HinfI for rs2049046) and 
electrophoretic separation on EtBr-stained 
agarose gels, genotypes were visualized under 
UV transillumination. Fragment lengths were 
151+189+317bp (A) or 189+468bp (G) for 
rs3812047, 133+178bp (G) or 311bp (C) for 
rs1110149, 285+325bp (T) or 610bp (G) for 
rs884344, 72+236bp (G) or 308bp (A) for 
rs6265, and 58+196+206bp (A) or 58+402bp 
(T) for rs2049046. All alleles refer to the 
transcribed strand.  
 
Statistical analysis 
 
STATA 8.0 (Stata Corporation, College Station, 
TX, USA) was used for descriptive statistics, 
tests of allelic association and multiple 
regression. GDNF and BDNF allele frequencies 
from reference populations were retrieved from 
the literature and from human variation 
databases for comparison with the present data 
using Fisher's exact tests. The level of statistical 
significance was set at p<0.05 and a Bonferroni 
correction was applied to account for multiple 
comparisons. LD and conformity of genotype 
distributions with the Hardy-Weinberg 
equilibrium (HWE) was measured with 
HaploView 4.2 [29]. PS V2.1.15 [30] was used 
for power simulations. The Shapiro–Wilk 
statistic served to test the null hypothesis of 
normally distributed TQ scores. To minimize 
trade-offs in statistical power, heterozygous 
subjects and subjects homozygous for the minor 
alleles were collapsed into a single group under 
the assumption of dominant effects of the 
minor alleles [31]. Separate multiple regression 
models were calculated for male and female 
subjects based on epidemiological evidence of 
gender differences in presentation [32-34]. 
 
Results 
 
All genotype distributions conformed to the 
Hardy-Weinberg Equilibrium. Overall, we noted 
only weak linkage disequilibrium between 
variants (Figure 1) and heterozygosities 
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between 0.21 (rs 3812047) and 0.50 
(rs1110149). With regard to single markers, the 
comparison of allele frequencies with reference 
data gave an uncorrected p value of <0.05 for 
two variants (rs6265 and rs1110149), but this 
finding did not survive corrections for multiple 
testing (Table 1). Still, a weak modulatory effect 
could not entirely be ruled out. According to 
power simulations based on the entire sample 
of tinnitus patients and all Caucasian control 
populations, we should require close to 15,000 
affecteds and over 680,000 healthy controls in 
order to exclude a modifying role of rs6265 on 
allelic risk with a statistical power of 0.8. 
 
We then interrogated possible effects of BDNF 
and GDNF variants on tinnitus severity. TQ 
scores averaged 41.0 ± 1.2 (mean ± SEM) out 
of 84 points (N=236). By this measure, tinnitus 
was rated mild (0–30 points) in 73 subjects 
(30.9%), moderate (31–46 points) in 73 
subjects (30.9%), severe (47–59 points) in 45 
subjects (19.1%), and extreme (60–84 points) 
in 45 subjects (19.1%). There was no significant 
difference in mean TQ scores between carriers 
and non-carriers of the minor alleles (p>0.19) 
and neither the degree of concomitant hearing 
loss (uncorrected p>0.31, t-test) nor a positive 
family history of tinnitus in first-degree relatives 
predicted minor allele carrier status 
(uncorrected p>0.08, Fisher's exact test). 
However, when the joint effects of dichotomized 
GDNF and BDNF genotypes were examined in 
multiple regression models using log-
transformed, normally distributed TQ scores as 
the dependent variable and correcting for the 
effect of age, tinnitus severity was predicted in 
women (F=2.32, uncorrected p=0.04), as 
opposed to men (F=1.16, n.s., Figure 2). Under 
these assumptions, minor allele carrier status 
explained 19.1% of the variance in tinnitus 
severity of the female subgroup.  
 
Discussion 
 
The present investigation provides original 
information on the contribution made by 
neurotrophic factor genes to predicting the 
intensity of tinnitus. Earlier research has 
suggested an inverse correlation of BDNF 
plasma levels with symptom severity in tinnitus 
sufferers [35] which could be explained by 
differences in secretion and is in line with 
neurotrophic support in adulthood [36]. While 
we failed to observe any major effects of 
individual BDNF or GDNF variants on 
susceptibility to the phenotype, the findings are 
compatible with minor, additive effects. Such 
effects would appear to be gender-sensitive 
according to subjective ratings of symptoms, 
offering a possible explanation for distinct 
patterns of central nervous activity in tinnitus 
[37]. 
 
If substantiated in larger studies, a differential 
role for GDNF and BDNF genotypes in predicting 
auditory symptoms of men and women could 
relate to the effects of estrogen on neurotrophic 
factor gene transcription [38, 39]. Speculations 
on a specific role in tinnitus, however, will need 
to be postponed until the predictors have been 
evaluated in hearing sensitivity [40-42], in the 
cortical response to background noise [43], or 
more generally, in the subcortical and cortical 
processing of auditory information [44, 45], all 
of which exhibit sex differences. Finally, 
developmental differences in the primary 
auditory cortex have long been noted [46] and 
distinct capabilities for the restoration of 
auditory function in men and women are 
emerging, e.g. in adult cochlear implants [47]. 
Exploitation of these phenotypes should 
promote the identification of genetic subgroups 
with high and low potentials for restoring the 
Figure 1. LD plots and R2x100 values for the variants 
investigated. A BDNF coding variant is indicated in 
green. Markers span 43.9kb on the BDNF gene and 
11.4kb on the GDNF gene, corresponding to 65% and 
42% of the respective genomic sequence. 
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integrity of the auditory pathway in altered 
states of neural excitation or inhibition. 
 
It also remains to be seen whether additional 
clinical features of tinnitus, e.g., the response to 
treatment, can be predicted from variation in 
neurotrophic factor genes. Preliminary data 
suggest that antidepressant-responsive forms 
of tinnitus may indeed be more common in 
women [48], but it is not yet known whether this 
Table 1. Observed genotype and allele frequencies in subjects with chronic tinnitus (N=240) and tests 
for allelic association. Data from nine Caucasian control populations were used with Bonferroni 
corrections. 
dbSNP 
identifier 
gene 2N major:minor 
allele 
(1:2) 
predicted 
protein 
variant 
genotypes 
(11:12:22) 
MAF in 
chronic 
tinnitus 
MAF in 
unrelated 
Caucasian 
controls (N) 
  passociation 
(pcorrected) 
rs2049046 BDNF 480 A:T - 69:105:66 0.494 0.467 (379)a   n.s. 
0.481 (128) [51] n.s. 
0.476 (287) [52] n.s. 
rs6265 BDNF 480 G:A V66M 155:76:9 0.196 0.191 (4299)b   n.s. 
0.203 (379)a   n.s. 
0.137 (128) [51] 0.05 (0.74) 
0.190 (2100) [53] n.s. 
0.213 (839) [54] n.s. 
0.185 (664) [55] n.s. 
0.218 (333) [56] n.s. 
0.175 (2184) [57] n.s. 
rs1110149 GDNF 480 G:C - 62:121:57 0.490 0.410 (379)a   0.007 
(0.10) 
rs884344 GDNF 480 T:G - 125:101:14 0.269 0.236 (379)a   n.s. 
rs3812047 GDNF 476 G:A - 178:52:8 0.143 0.144 (379)a   n.s. 
all alleles refer to the transcribed strand, MAF = minor allele frequency. areference population of European ancestry from the 1000 
Genomes Project, July 2010 data release (URL: http://www.1000genomes.org), accessed July 2012; breference population of 
European ancestry from the NHLBI GO Exome Sequencing Project. Data retrieved with the Exome Variant Server (URL: http://
evs.gs.washington.edu/EVS/), accessed July 2012. 
 
Figure 2. TQ scores (mean ±SEM) for men and women with chronic tinnitus stratified by minor allele carrier status 
(N=236). p values refer to multiple regression models using GDNF and BDNF genotypes as independent variables 
and correcting for the effect of age. For ease of interpretation, reported means and SEMs are not log-transformed. 
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dimorphism is due to the induction of 
neurotrophic factor signalling or downstream 
effects on synaptic plasticity [49].  
 
We acknowledge three caveats. Firstly, with 
regard to the case-control-approach, it cannot 
be excluded that among the >11,200 external 
control subjects some suffered from mild forms 
of tinnitus that were not reported during 
recruitment. Possible heterogeneity of control 
samples was only addressed by verifying the 
conformity of these data with HWE. Future 
investigations will therefore need to ascertain 
auditory control status in more detail. Secondly, 
with regard to the quantitative trait analysis, we 
postulated a dominant mode of inheritance for 
all minor alleles. An alternative approach would 
have been to examine all possible modes of 
inheritance for each biallelic SNP, at the price of 
inflating the number of tests from 1 to 35=243. 
Thirdly, of the variants examined, only rs6265 is 
known to affect activity-dependent secretion of 
BDNF [50]. rs2049046, rs1110149, rs884344, 
and rs3812047 map to intronic regions of 
uncertain functionality. Effects could point at 
the existence of variants that affect gene 
transcription and are in tight LD with the SNPs 
genotyped here but validation is currently 
lacking. 
 
With the above limitations in mind, and pending 
replication, BDNF and GDNF variants may prove 
helpful in assessing the potential for symptom 
control in well-defined tinnitus subpopulations. 
Longitudinal studies are invited to put these 
results into perspective and to specify the 
dynamics of explanatory variables in the context 
of neural plasticity. 
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